Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
AI-designed drug for inflammatory bowel disease enters human clinical trials: 'A significant need'
Inflammatory bowel disease (IBD) impacts 1.6 million people in the U.S. — and a new artificial intelligence-generated drug ...
GIZBOT18h
Best AI-Powered Smartphones (January 2025) in India
Here we have listed the best smartphones that let you experience AI capabilities to the fullest. Without any delays, here are the best AI-Powered mobiles (January 2025) that make the cut: Read More ...